Editorial: Do practice patterns reflect practice guidelines?

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1478-1480

  Yen, Tina W F ^a   Evans, Douglas B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURGERY; CLINICAL PRACTICE; COMORBIDITY; EDITORIAL; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; THYROID CANCER; MEDULLARY CARCINOMA; NOTE; ORGANIZATION; PRIMARY HEALTH CARE; STANDARD; THYROID TUMOR; TREATMENT OUTCOME; UNITED STATES;

CARCINOMA, MEDULLARY; CONGRESSES AS TOPIC; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; THYROID NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

EID: 77954815176     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1020-5     Document Type: Editorial

References (21)

1. Panigrahi B, Roman SA, Sosa JA. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? Ann Surg Oncol. doi:10.1245/s 10434-010-1017-0.
2. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
3. Surveillance Epidemiology and End Results. Overview of the SEER program. http://www.seer.cancer.gov. Accessed February 2010.
4. Centers for Medicare and Medicaid Services. Research, statistics, data and systems. http://www.cms.hhs.gov/home/rsds.asp. Accessed February 2010.
5. Healthcare Cost and Utilization Project (HCUP). http://www.hcup-us.ahrq. gov. Accessed February 2010.
6. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1-48.
7. Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153-1159
8. National Comprehensive Cancer Network. Clinical practice guidelines for medullary thyroid carcinoma. 2010. http://www.nccn.org/professionals/physician- gls/f-guidelines.asp. Accessed February 2010.
9. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol. 2005;23:619-629
10. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-7720
11. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091-5097
12. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-5312
13. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145
14. Pestalozzi BC, Luporsi-Gely E, Jost LM, Bergh J. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol. 2005;16 (Suppl 1):i7-9. (Pubitemid 40872969)
15. National Comprehensive Cancer Network. Clinical practice guidelines for breast cancer. 2010. http://www.nccn.org/professionals/physician-gls/f- guidelines.asp. Accessed February 2010.
16. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16:1569-1583 (Pubitemid 41511089)
17. National Comprehensive Cancer Network. Pancreatic adenocarcinoma. 2009. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed February 2010.
18. Evans DB, Farnell MB, Lillimoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1736-1744
19. Abrams RA, Lowy AM, O'Reilly EM, et al. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1751-1756
20. Tanaka M, Chari S, Adsay V, et al. International consensus guide for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
21. National Comprehensive Cancer Network. Neuroendocrine tumors. 2009. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed February 2010.